Sunicine Sunitinib Malate Capsules 50 mg

Product Description

Sunicine (Sunitinib Malate) Capsules 50 mg contain sunitinib malate, a medication used primarily for the treatment of certain types of cancer. It is a tyrosine kinase inhibitor (TKI) that works by blocking specific enzymes (tyrosine kinases) that are involved in cancer cell growth and the formation of blood vessels that supply tumors (angiogenesis).

Common uses of Sunicine (Sunitinib):

1. Renal cell carcinoma (RCC): Sunitinib is commonly used to treat advanced kidney cancer (renal cell carcinoma), especially in cases that are not amenable to surgery.
2. Gastrointestinal stromal tumors (GISTs): It is used for GISTs that cannot be surgically removed or have spread to other parts of the body, particularly when other treatments are ineffective.
3. Pancreatic neuroendocrine tumors (pNETs): Sunitinib is also used to treat pancreatic neuroendocrine tumors that are not surgically removable or have metastasized.

How it works:

Sunitinib targets and inhibits multiple tyrosine kinases involved in processes that promote cancer cell growth, blood vessel formation (angiogenesis), and tumor spread. It blocks vascular endothelial growth factor receptors (VEGFR) and platelet-derived growth factor receptors (PDGFR), which are involved in tumor development and blood vessel formation, helping to slow the growth of the tumor and prevent its spread.

Common side effects of Sunicine (Sunitinib):

• Fatigue or tiredness
• Diarrhea
• Nausea and vomiting
• High blood pressure (hypertension)
• Hand-foot syndrome (redness, swelling, or pain on the palms of the hands or soles of the feet)
• Loss of appetite or weight loss
• Mouth sores or stomatitis
• Skin rash
• Liver function changes: Liver enzymes may increase, requiring regular monitoring.
• Low blood counts: Sunitinib can reduce white blood cells, red blood cells, and platelets, increasing the risk of infection, anemia, or bleeding.

Important considerations:

• Blood pressure monitoring: Sunitinib can cause high blood pressure, so blood pressure should be regularly monitored. If blood pressure becomes high, your doctor may prescribe antihypertensive medication.
• Heart function: Some patients on sunitinib may experience heart problems, such as heart failure or reduced ejection fraction. This should be monitored with regular checkups.
• Liver function: As sunitinib can affect liver function, routine liver enzyme tests are required during treatment.
• Drug interactions: Sunitinib can interact with other medications, including drugs that affect liver enzymes. Always inform your healthcare provider about any other medications you are taking.
• Pregnancy and breastfeeding: Sunitinib is contraindicated during pregnancy due to the risk of fetal harm. It should also not be used while breastfeeding.

Administration:

• Sunitinib is usually taken as an oral capsule once daily, with or without food. The dosage and schedule are typically based on your specific cancer type, the stage of the disease, and how you respond to the medication.
• Schedule: Sunitinib is often given in a schedule of 4 weeks on treatment followed by 2 weeks off (a 4/2 cycle), but your doctor will determine the most appropriate schedule for your specific case.

Sunitinib can be an effective treatment for several types of cancer, but it requires careful monitoring due to its potential side effects. Always follow your healthcare provider™s instructions and attend regular follow-up appointments to monitor the treatment's effectiveness and any side effects.